CTS Publishes New Guidelines on Alpha-1 Antitrypsin Deficiency

The CTS COPD Clinical Assembly is delighted to announce the publishing of "Alpha-1 Antitrypsin Deficiency Targeted Testing and Augmentation Therapy: A Canadian Thoracic Society Clinical Practice Guideline". This clinical practice guideline provides evidence-based recommendations on targeted testing and augmentation therapy for alpha-1 antitrypsin deficiency (A1AT) in COPD patients.

It is intended for all healthcare professionals involved in the care of patients suffering from COPD attributable to A1AT deficiency or patients for whom targeted testing of A1AT deficiency is being considered.

 Full Guidelines Available Here...